Global Infusion Systems Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape

News provided by

Jan 17, 2024, 12:15 ET

DUBLIN, Jan. 17, 2024 /PRNewswire/ -- The "Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

Infusion Systems Pipeline Report provides comprehensive information about the Infusion Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Infusion systems are used to administer medication to a patient in critical care, emergency care, home care and trauma centres.

The report provides comprehensive coverage of the Infusion Systems currently under development, offering a deep dive into this vital healthcare sector. It meticulously examines the specifics of major pipeline products, encompassing thorough product descriptions, licensing agreements, collaboration details, and other essential developmental activities that are shaping the landscape of infusion systems.

Furthermore, the report scrutinizes the major players actively driving innovation in Infusion Systems, presenting a comprehensive catalog of their ongoing pipeline projects. This coverage spans the entire spectrum of development stages, ranging from early conceptualization to products in the approved and issued stages, delivering a holistic view of the evolving realm of infusion systems.

Additionally, the report furnishes essential clinical trial data pertinent to ongoing trials linked to these pipeline products. It also keeps stakeholders informed about the most recent developments within the infusion systems segment and the broader industry, ensuring that they stay abreast of the latest trends and advancements in this critical field.

Reasons to Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Infusion Systems under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Infusion Systems Overview

3 Products under Development
3.1 Infusion Systems - Pipeline Products by Stage of Development
3.2 Infusion Systems - Pipeline Products by Segment
3.3 Infusion Systems - Pipeline Products by Territory
3.4 Infusion Systems - Pipeline Products by Regulatory Path
3.5 Infusion Systems - Pipeline Products by Estimated Approval Date
3.6 Infusion Systems - Ongoing Clinical Trials

4 Infusion Systems - Pipeline Products under Development by Companies
4.1 Infusion Systems Companies - Pipeline Products by Stage of Development
4.2 Infusion Systems - Pipeline Products by Stage of Development

5 Infusion Systems Companies and Product Overview

6 Infusion Systems- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

410 Medical Inc
AbbVie Inc
Acuros GmbH
Adept Medical Ltd
Agitated Solutions LLC
Albireo Pharma Inc
Alnylam Pharmaceuticals Inc
Arnali, LLC
Avoset Health Ltd
Baxter Healthcare Corp
Baxter International Inc
Becton Dickinson and Co
BioQ Pharma Inc
ClearLine MD
Cognos Therapeutics Inc
Debiotech SA
Eksigent Technologies, LLC
Eli Lilly and Co
EryDel SPA
Flowonix Medical Inc
Fluid Synchrony LLC
Fluonic, Inc. (Inactive)
Fresenius Medical Care AG & Co KGaA
HAI Solutions Inc
Hospira Inc
ICU Medical Inc
Infusense Corp
Innofuse BV
Innovative Health Sciences LLC
Innovfusion Pte. Ltd.
Intarcia Therapeutics Inc
IRadimed Corp
KORU Medical Systems Inc
LifeMedix, LLC
Lynntech Inc
Massachusetts Institute of Technology
Medical Device Creations Ltd.
Medovate Ltd
MonuMedical LLC
Neurochase Ltd
NexGen Medical Systems Inc
Palyon Medical Corp (Inactive)
Pavmed Inc
PRO-IV Medical Ltd
Ratio Inc
Rice University
Sensile Medical AG
Shenox Pharmaceuticals LLC
Shift Labs Inc
SQ Innovation AG
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Starton Therapeutics Inc
SteadyMed Therapeutics Inc
StnDrd Infusion Corporation
Supernus Pharmaceuticals Inc
Terumo Corp
ToucheMedical Ltd.
TriSalus Life Sciences Inc
Turnpoint Medical Devices Inc
U-Needle BV
Unilife Corporation
United Therapeutics Corp
University of Minnesota
University of Southern California
Zealand Pharma AS

For more information about this report visit https://www.researchandmarkets.com/r/io5tb6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets